drugset / Trial / NCT06062355
Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
The study is being conducted to evaluate the the safety, pharmacokinetics, radiation dosimetry of HRS-9815 for PET/CT imaging in adult patients with prostate cancer.
Timeline
- Start
- 2023-10
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-9815 | Diagnostic / imaging agent | — | — |